SciBase Holding AB (publ) (FRA:5J3)

Market Cap	38.88M +337.1%
Revenue (ttm)	3.74M +36.2%
Net Income	-8.04M
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	5,000
Open	0.0128
Previous Close	0.0132
Day's Range	0.0128 - 0.0128
52-Week Range	0.0002 - 0.0422
Beta	n/a
RSI	53.15
Earnings Date	May 7, 2026

About SciBase Holding AB

SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin cancer; and for research within skin barrier assessment. It has a collaboration with Mayo Clinic on pigmented lesion digital workflows with AI-driven Ne...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1998
• Employees: 46
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 5J3

Financial Performance

In 2025, SciBase Holding AB's revenue was 40.46 million, an increase of 36.21% compared to the previous year's 29.71 million. Losses were -87.06 million, 42.4% more than in 2024.

Financial numbers in SEK